SCHEMBL2536315

SCHEMBL2536315

O=c1c(O)c(CCCCCO)oc2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 5/20 0.48
▸ MEN1 O00255 5/20 0.48
▸ KMT2A Q03164 5/20 0.48
▸ KDM4E B2RXH2 5/20 0.48
▸ MAPK1 P28482 4/20 0.48
▸ ALOX15 P16050 3/20 0.48
▸ TP53 P04637 3/20 0.48
▸ LMNA P02545 2/20 0.48
▸ CA12 O43570 1/20 0.48
▸ CA1 P00915 1/20 0.48
▸ CA2 P00918 1/20 0.48
▸ ABCB1 P08183 1/20 0.48
▸ CALM1 P0DP23 1/20 0.48
▸ AR P10275 1/20 0.48
▸ PKM P14618 1/20 0.48
▸ CYP1B1 Q16678 1/20 0.48
▸ CA9 Q16790 1/20 0.48
▸ HSD17B10 Q99714 4/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ HPGD P15428 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19732866 0.87 PTPN1 (0.52) LMNAALDH1A1TSHRHTTCYP2C9
SCHEMBL957193 0.85 PTPN1 (0.53) LMNAALDH1A1TSHRHTTCYP2C9
SCHEMBL15528187 0.75 CA1 (0.54) CYP3A4MEN1KMT2AKDM4EMAPK1
SCHEMBL7596849 0.72 PPARG (0.61) CYP3A4KDM4EALOX15TP53LMNA
SCHEMBL28422971 0.72 PPARG (0.61) CYP3A4KDM4EALOX15TP53LMNA
SCHEMBL18407426 0.71 PPARG (0.47) CYP3A4KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL1180659 0.70 KDM4E (0.62) CYP3A4MEN1KMT2AKDM4EMAPK1
SCHEMBL8934502 0.70 NQO1 (0.69) CYP3A4MEN1KMT2AKDM4EMAPK1
SCHEMBL19732865 0.70 PTPN1 (0.51) LMNAHTTPTPN1
SCHEMBL18407429 0.70 EYA3 (0.49) CYP3A4KDM4EHSD17B10ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2561334-A1 PRODUCTS AND METHODS FOR TISSUE PRESERVATION Genvault Corporation (US) 2013-02-27 — — EP disclosed
WO-2011130280-A1 PRODUCTS AND METHODS FOR TISSUE PRESERVATION GENVAULT CORPORATION (US) 2011-10-20 — — WO disclosed
US-20110256530-A1 PRODUCTS AND METHODS FOR TISSUE PRESERVATION GENVAULT CORPORATION (US) 2011-10-20 — — US disclosed
EP-1124814-B1 AROMATIC DERIVATIVES AND IRON COMPLEXES THEREOF FOR THE USE AS NORMALISING AGENTS OF THE IRON LEVEL MEDIDOM LAB (CH) 2002-12-18 — — EP disclosed
US-6455578-B1 IRON CHELATING AGENTS FOR TREATMENT OF IRON OVERLOAD AND ANEMIA. LABORATOIRE MEDIDOM S.A. (CH) 2002-09-24 — — US disclosed
EP-1124814-A1 AROMATIC DERIVATIVES AND IRON COMPLEXES THEREOF FOR THE USE AS NORMALISING AGENTS OF THE IRON LEVEL LABORATOIRE MEDIDOM S.A. (CH) 2001-08-22 — — EP disclosed
WO-2000026205-A1 AROMATIC DERIVATIVES AND IRON COMPLEXES THEREOF FOR THE USE AS NORMALISING AGENTS OF THE IRON LEVEL LABORATOIRE MEDIDOM S.A. (CH) 2000-05-11 — — WO disclosed
Send feedback